Omass (AgeTech UK) Biomed
High-res Mass Spec drug discovery: G-protein receptor, immuno-dysregulation, protein-protein interactions.
Funding Status:
N/A
Headquarters:
United Kingdom
Founded Date:
N/A
Investor Type:
N/A
Investment Stage:
N/A
Technology:
AgeTech Companies
Employee Number:
N/A
Number Of Exists:
N/A
Industry:
UK AgeTech 2020